Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsManagement of Periprosthetic Hip Joint InfectionTreatment of acute periprosthetic infections with prosthesis retention: Review of current conceptsImplant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Surgical treatment approaches and reimbursement costs of surgical site infections post hip arthroplasty in Australia: a retrospective analysis.Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.Aggressive early débridement for treatment of acutely infected cemented total hip arthroplasty.Failure of irrigation and débridement for early postoperative periprosthetic infectionOutcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapyPathogen-driven decision for implant retention in the management of infected total knee prostheses.Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients.Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection.One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcomePeriprosthetic infection due to resistant staphylococci: serious problems on the horizon.Treatment results with debridement and retention of infected hip prostheses.Aggressive Early Debridement in Treatment of Acute Periprosthetic Joint Infections After Hip and Knee Replacements.Rifampin combination therapy for nonmycobacterial infections.Acute Delayed or Late Infection of Revision Total Hip Arthroplasty Treated with Debridement/Antibiotic-loaded Cement Beads and Retention of the Prosthesis.Emerging drugs for complicated skin and skin-structure infections.Prosthetic joint infection: challenges of diagnosis and treatment.Prosthetic joint infection: diagnosis and management.Current concepts in the management of prosthetic joint infection.Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention?Efforts to support the development of fusidic acid in the United States.Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review.Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction.Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus.Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.Management of Acute Hematogenous Infection Following Total Knee Arthroplasty: A Case Series of 11 Patients.[Treatment of periprosthetic infections].Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.Open debridement and prosthesis retention is a viable treatment option for acute periprosthetic joint infection after total knee arthroplasty.[Periprosthetic infections of the hip joint : Clinical approach].Irrigation and debridement.Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics: functional outcomes, quality of life and complications.Is there still a place for continuous closed irrigation in the management of periprosthetic total knee infection?
P2860
Q21131083-449C9FC1-1061-403B-8F87-5F02A825D94DQ27015829-813A614F-B0CF-4139-B93C-90D710AD1598Q27022797-60A89332-FEF1-4BF8-B4A7-69A4B8C8D241Q28071834-874CBD99-2B2B-4618-8A8E-3638128F6098Q34157657-B9181A4A-6CF2-4680-B214-BEE473C601C5Q34623408-1746485B-EEAF-4EBE-8264-DA59D6E5EBE9Q35141244-BE942892-2F10-4DFB-AD5B-CFFD92CFD4C1Q36293329-08F2D028-179E-426E-A2A4-106393F28593Q36484891-6627660B-A4D5-442F-8DD5-DF67772D4F6EQ36505327-A6929E24-B033-4321-B3B3-053E18118092Q37057488-8F771C03-3B28-4904-A931-06083B2696D2Q37120112-889357DE-B061-4338-B1B0-2AB3219B9907Q37158397-22CB4420-B5B5-46F3-96DA-829D84B87315Q37170879-40CD4A79-4168-4352-909E-65EF1C7EA14EQ37187474-084D27CD-5400-4F00-B073-5742C15080ECQ37213252-9485A825-9C97-45A4-8E6F-FC5CF4531413Q37487775-FA3EB011-5BB0-4CE9-A20F-D810DD2C1956Q37570739-854E3365-78B3-4A4D-AFCC-E4EABE01B75BQ37672039-BE9FA523-D5D0-40CF-AF56-B7600388BEDEQ37703145-070FF1E9-75EA-4390-BFF5-31BA30DC8C0DQ37765900-0FEE1ACF-4BD4-4B8E-A74E-1EC70A116027Q37837071-D4366035-A40C-4CEB-B3D7-0243D40D7512Q37929757-CF9B467D-5DB2-4550-AAF3-A47E88F78ED7Q38221335-F6DA5AB0-56EC-43C9-8E7A-29E960932FC4Q38230862-F8B7467A-0C1E-4782-8531-AD8846BCCB8FQ38428027-9A2B88F6-2279-4A5A-B4F4-55C0DF8A30E7Q38450497-C77DF74A-F5A6-44DF-B1AF-4CF5E217D9B4Q38686596-2EC65E90-7C3E-407B-8E40-2D903FCB4C75Q38793280-3627F795-0D10-4906-A4D4-ADD4620C160EQ38816706-91795651-C1CF-4D21-B494-A96F20894CFDQ39135819-25E5F30E-8870-4E80-87BD-D1B4C9BC2862Q39367796-97F44986-17CE-4912-BA5A-BF18822DABF3Q40391738-8710B19C-AAD7-49CD-8438-EEF0CE0F1F43Q40590767-42BC74C7-5485-4B10-B760-17841C36C67CQ40918518-08160BF1-AD26-45D8-A969-86DF1FA201DCQ41254478-08534519-270A-4216-B363-29FE09E92EC7Q41393186-A2683F1F-751D-4D2F-A960-7D7688825995Q42231216-E0F7D0D1-9FB6-41C6-9868-249CD20AD2ECQ42263779-672D1A8C-D764-451D-B12D-B7D701A4CA4AQ43063538-6DF215EA-BBEF-424C-9A75-CFF0816C21D9
P2860
Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@ast
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@en
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@nl
type
label
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@ast
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@en
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@nl
prefLabel
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@ast
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@en
Treatment of staphylococcal pr ...... l rifampicin and fusidic acid.
@nl
P2093
P50
P1476
Treatment of staphylococcal pr ...... al rifampicin and fusidic acid
@en
P2093
P304
P356
10.1111/J.1469-0691.2007.01691.X
P577
2007-02-28T00:00:00Z